| Literature DB >> 29510003 |
Pujiang Shi1, Yong Sheng Edgar Tan1, Wai Yee Yeong1, Hoi Yeung Li2, Augustinus Laude3,4,5.
Abstract
ARPE-19 and Y79 cells were precisely and effectively delivered to form an in vitro retinal tissue model via 3D cell bioprinting technology. The samples were characterized by cell viability assay, haematoxylin and eosin and immunofluorescent staining, scanning electrical microscopy and confocal microscopy, and so forth. The bioprinted ARPE-19 cells formed a high-quality cell monolayer in 14 days. Manually seeded ARPE-19 cells were poorly controlled during and after cell seeding, and they aggregated to form uneven cell layer. The Y79 cells were subsequently bioprinted on the ARPE-19 cell monolayer to form 2 distinctive patterns. The microvalve-based bioprinting is efficient and accurate to build the in vitro tissue models with the potential to provide similar pathological responses and mechanism to human diseases, to mimic the phenotypic endpoints that are comparable with clinical studies, and to provide a realistic prediction of clinical efficacy.Entities:
Keywords: age-related macular degeneration (AMD); bioprinting; retina; retinoblastoma; tissue model
Mesh:
Year: 2018 PMID: 29510003 DOI: 10.1002/term.2661
Source DB: PubMed Journal: J Tissue Eng Regen Med ISSN: 1932-6254 Impact factor: 3.963